Ming Ye

Ming Ye

Auto-generated profile, based on publicly available information

Ming Ye

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2025 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
XSXin Su
Xin Su
YMYongjie Ma
Yongjie Ma
ZSZihao Song
Zihao Song
HLHuiwei Liu
Huiwei Liu
CZChao Zhang
Chao Zhang
PZPeng Zhang
Peng Zhang
Background: Intracranial dural arteriovenous fistulas (DAVFs) are rare lesions, making it challenging to fully understand and improve their management. Globally, only two major large-scale studies have focused on DAVFs. This report outlines the design of the DREAM-INI (Dural arteriovenous fistula research and management in China) project and provides an overview of the 1101-patient cohort it includes. Methods: Patient data were sourced from the DREAM-INI database, a retrospective, single-center observational study conducted from January 2001 to December 2022, encompassing a total of 1101 DAVF patients. Results: The cohort consists of 367 patients diagnosed with Borden type I DAVFs, 172 patients with Borden type II fistulas, and 562 patients with Borden type III fistulas. 565 patients exhibited flow-related symptoms, 176 patients presented with intracranial hemorrhage, and 275 patients had non-hemorrhagic neurological deficits. A large proportion of patients (95.6%, 1053/1101) underwent treatment through endovascular embolization (83.7%, 922/1101), surgery (8.7%, 96/1101), or multimodal therapy (3.2%, 35/1101). The overall immediate angiographic cure rate was 85.2% (897/1053 treated cases), and the rate of treatment-related permanent neurological morbidity was 3.4% (45/1328 total procedures). The median duration from the final treatment to the last follow-up for DAVF was 39 months. The predictive factors for aggressive symptoms, initial angiographic cure, and complications in DAVFs have also been preliminarily explored. Conclusions: With over 1100 patients, DREAM-INI represents a large and relatively well-documented registry of DAVF patient data in China and even globally. This database will enable numerous future studies, further advancing our understanding of this rare disease.

1 September 2020 in World Neurosurgery
Verified
Journal Article
Closed access
LSLiyong Sun
Liyong Sun
JRJian Ren
Jian Ren
LWLong Wang
Long Wang
JLJingwei Li
Jingwei Li
CHChuan He
Chuan He
HZHongqi Zhang
Hongqi Zhang

20 July 2018 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
MYMing Ye
Ming Ye
PZPeng Zhang
Peng Zhang

1 January 2019 in World Neurosurgery
Verified
Journal Article
Closed access
LJLidan Jiang
Lidan Jiang
MQMeng Qi
Meng Qi
MYMing Ye
Ming Ye
MLMeng Li
Meng Li
YBYuhai Bao
Yuhai Bao
JLJiantao Liang
Jiantao Liang

4 November 2023 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
ZSZihao Song
Zihao Song
YMYongjie Ma
Yongjie Ma
XSXin Su
Xin Su
YFYuxiang Fan
Yuxiang Fan
HZHongqi Zhang
Hongqi Zhang
PZPeng Zhang
Peng Zhang

1 July 2018 in World Neurosurgery
Verified
Journal Article
Closed access
MYMing Ye
Ming Ye
PZPeng Zhang
Peng Zhang